W.A. Harris talks about his new book, “Zero to Birth: How the Human Brain Is Built,” which illustrates how one cell develops into the complex operational centers that not only make us human, but also individuals.
A new study by Harvard-affiliated researchers finds that patients with Alzheimer’s disease have both more and different somatic mutations — alterations in DNA — in their brain cells than people without Alzheimer’s disease.
Researchers have used a genetic engineering strategy to dramatically reduce levels of tau — a key protein that accumulates and becomes tangled in the brain during the development of Alzheimer’s disease — in an animal model of the condition.
A team of researchers has developed an artificial intelligence-based method to screen currently available medications as possible treatments for Alzheimer’s disease. The method could represent a rapid and inexpensive way to repurpose existing therapies.
Researchers have developed a software-based method of scanning electronic health records to estimate the risk that a healthy person will receive a dementia diagnosis in the future.
A new study provides insights on why some people may be more resistant to Alzheimer’s disease than others.
A new paper explores why neuron-like implants could offer a better way to treat brain disorders, control prosthetics, or even enhance cognitive abilities.
Research into extending humanity’s healthy lifespan has been progressing rapidly in recent years. In February, a group of aging and longevity scientists founded a nonprofit to foster the work and serve as a resource for governments and businesses looking to understand the potentially far-reaching implications of a population that lives significantly longer, healthier lives.
/
2
